Calcitonin-salmon

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCalcitonin-salmon
Drug Alias NameSalcatonin intranasal - NovartisMiacalcin Nasal SprayMiacalcin intranasalMiacalcin InjectionMiacalcin
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionCalcitonin receptor agonists
TargetsCalcitonin receptor
Therapy Area/IndicationsHypercalcemiaOsteitis DeformansOsteoporosis, Postmenopausal
Global Approved IndicationsHypercalcemiaOsteitis DeformansOsteoporosis, Postmenopausal
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1975/01/01
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMylan NvNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHypercalcemiaOsteitis DeformansOsteoporosis, Postmenopausal
Inactive IndicationsN/A

Other Information

ATC CodeH05BA01
Related LinksN/A